Last updated on June 2018

Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ankylosing spondylitis
  • Age: Between 18 - 70 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with spondyloarthritis validating ASAS or modified New York criteria for which adalimumab treatment is indicated, and performing the pre-biotherapy assessment;
  • Between 18 and 70 years old;
  • Biotherapy naive;
  • Who can be regularly monitored for 6 months;
  • Able to take all the treatment;
  • Effective contraception for patients of childbearing age (oral contraceptive, intrauterine device, implant, spermicide, surgical sterilization or abstinence) during the study and at least for 5 months after the last injection;
  • Able to read and understand the terms of the protocol;
  • Having dated and signed the informed consent form of the trial;
  • Affiliated to a social security scheme.

Exclusion Criteria:

  • Patients having a contraindication to an anti-TNF;
  • Surgical operation scheduled during the trial;
  • Having difficulty understanding the French language;
  • Having impaired upper functions (dementia of Alzheimer type, etc...);
  • Psycho-social instability incompatible with regular follow-up (homeless, addictive behavior, history of psychiatric pathology or any other comorbidity which would make a free and informed consent impossible or limit adherence to the protocol);
  • Having previously received a biotherapy. There is no other exclusion criteria taking into account prior therapies and the duration of these therapies;
  • Described in articles L.1121-5 to L.1121-8 of the Personal Status Code: pregnant, parturient and nursing women; persons in detention by judicial or administrative decision; adults subject to a legal protection order;
  • Already participating in interventional research.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.